These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 13034453)

  • 1. Use of adjuvants in studies on influenza immunization. III. Degree of persistence of antibody in human subjects two years after vaccination.
    SALK JE; CONTAKOS M; LAURENT AM; SORENSEN M; RAPALSKI AJ; SIMMONS IH; SANDBERG H
    J Am Med Assoc; 1953 Apr; 151(14):1169-75. PubMed ID: 13034453
    [No Abstract]   [Full Text] [Related]  

  • 2. ANTIBODY responses and clinical reactions with saline and oil adjuvant influenza virus vaccines.
    The Medical Research Council's Committee
    Br Med J; 1955 Nov; 2(4950):1229-32. PubMed ID: 13269837
    [No Abstract]   [Full Text] [Related]  

  • 3. Predetermination by infection and by vaccination of antibody response to influenza virus vaccines.
    DAVENPORT FM; HENNESSY AV
    J Exp Med; 1957 Dec; 106(6):835-50. PubMed ID: 13481247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly Adults.
    Lazarus R; Kelly S; Snape MD; Vandermeulen C; Voysey M; Hoppenbrouwers K; Hens A; Van Damme P; Pepin S; Leroux-Roels I; Leroux-Roels G; Pollard AJ
    PLoS One; 2016; 11(11):e0165384. PubMed ID: 27814377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to influenza vaccine in people with non-protective HI antibody titers.
    Baldo V; Baldovin T; Floreani A; Minuzzo M; Trivello R
    Eur J Epidemiol; 2006; 21(11):843-5. PubMed ID: 17082899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective immunization against influenza in pediatric renal transplant recipients.
    Edvardsson VO; Flynn JT; Deforest A; Kaiser BA; Schulman SL; Bradley A; Palmer J; Polinsky MS; Baluarte HJ
    Clin Transplant; 1996 Dec; 10(6 Pt 1):556-60. PubMed ID: 8996778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A serologic recapitulation of past experiences with influenza A; antibody response to monovalent vaccine.
    DAVENPORT FM; HENNESSY AV
    J Exp Med; 1956 Jul; 104(1):85-97. PubMed ID: 13332182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different influenza vaccine formulations and adjuvants for childhood influenza vaccination.
    Esposito S; Principi N
    Vaccine; 2011 Oct; 29(43):7535-41. PubMed ID: 21820478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of adjuvants in studies on influenza immunization. I. Measurements in monkeys of the dimensions of antigenicity of virus-mineral oil emulsions.
    SALK JE; LAURENT AM
    J Exp Med; 1952 May; 95(5):429-47. PubMed ID: 14927797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization.
    Chen D; Periwal SB; Larrivee K; Zuleger C; Erickson CA; Endres RL; Payne LG
    J Virol; 2001 Sep; 75(17):7956-65. PubMed ID: 11483740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of influenza antibodies by serum absorption.
    JENSEN KE; DAVENPORT FM; HENNESSY AV; FRANCIS T
    J Exp Med; 1956 Aug; 104(2):199-209. PubMed ID: 13345965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteosome-adjuvanted intranasal influenza vaccines: advantages, progress and future considerations.
    Burt D; Mallett C; Plante M; Zimmermann J; Torossian K; Fries L
    Expert Rev Vaccines; 2011 Mar; 10(3):365-75. PubMed ID: 21434804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus.
    Iorio AM; Bistoni O; Galdiero M; Lepri E; Camilloni B; Russano AM; Neri M; Basileo M; Spinozzi F
    Vaccine; 2012 Feb; 30(9):1617-23. PubMed ID: 22245606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic analysis of influenza viruses by complement fixation. VI. Implications of age distribution of antibodies to heterologous strains following infection and vaccination.
    LIEF FS; HENLE W
    J Immunol; 1960 Nov; 85():494-510. PubMed ID: 13762036
    [No Abstract]   [Full Text] [Related]  

  • 16. [Persistence of antibodies inhibiting hemagglutination by influenza viruses in aged vaccinated women. Changes in antibody titer after re-vaccination].
    Visconti M; Verde F; Frezza G; Russo V
    Boll Soc Ital Biol Sper; 1973 Feb; 49(4):173-7. PubMed ID: 4779760
    [No Abstract]   [Full Text] [Related]  

  • 17. Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59 (®) adjuvant: results from a dose-finding clinical trial in older adults.
    Della Cioppa G; Nicolay U; Lindert K; Leroux-Roels G; Clement F; Castellino F; Galli G; Groth N; Del Giudice G
    Hum Vaccin Immunother; 2012 Feb; 8(2):216-27. PubMed ID: 22426371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to 1 year after immunization with a pandemic A/H1N1 influenza vaccine in children 3 to < 9 years of age.
    Nassim C; Christensen S; Henry D; Holmes S; Hohenboken M; Kanesa-Thasan N
    Pediatr Infect Dis J; 2012 Apr; 31(4):e59-65. PubMed ID: 22418661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody persistence 1 year after pandemic H1N1 2009 influenza vaccination and immunogenicity of subsequent seasonal influenza vaccine among adult organ transplant patients.
    Felldin M; Andersson B; Studahl M; Svennerholm B; Friman V
    Transpl Int; 2014 Feb; 27(2):197-203. PubMed ID: 24289658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of oil adjuvant and aqueous influenza vaccines. II. Antibody responses to the vaccines.
    Forsyth JR; Russell EE
    J Hyg (Lond); 1967 Dec; 65(4):497-504. PubMed ID: 5235255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.